Artificial intelligence (AI) has enormous potential to support the pharmaceutical industry in discovering, developing and marketing medicines, but from a regulatory perspective, this rapidly advancing technology poses unique risks and challenges that must be addressed.
In a 19 July draft
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?